Evidence map›Paper›PMID 29100085›Full record

ArticleAmerican journal of human genetics2017

De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder.

Davor Lessel, Claudia Schob, Sébastien Küry, Margot R F Reijnders, Tamar Harel, Mohammad K Eldomery, Zeynep Coban-Akdemir, Jonas Denecke, Shimon Edvardson, Estelle Colin and 34 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Intracellular and Extracellular Vesicle miRNA Signatures in Human iPSC-Derived Neural Stem Cells and Floor Plate Progenitors.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Review
  6. Article
  7. Ribosome-associated proteins: unwRAPping ribosome heterogeneity in the twenty-first century.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 19 institutions in 6 countries.

Davor LesselInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Undiagnosed Disease Program at the University Medical Center Hamburg-Eppendorf (UDP-UKE), Martinistraße 52, 20246 Hamburg, Germany. Electronic address: d.lessel@uke.de.
Claudia SchobInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Sébastien KüryCHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes Cedex, France.
Margot R F ReijndersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Tamar HarelDepartment of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 9112001.
Mohammad K EldomeryDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Zeynep Coban-AkdemirDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Jonas DeneckeDepartment of Pediatrics, University Medical Center Eppendorf, 20246 Hamburg, Germany.
Shimon EdvardsonPediatric Neurology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 9112001; Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 9112001.
Estelle ColinDepartment of Biochemistry and Genetics, University Hospital, 49933 Angers Cedex 9, France; Equipe MitoLab, CNRS UMR 6015, Inserm U1083, Institut MitoVasc of Angers, CHU Bât IRIS/IBS, Rue des Capucins, 49933 Angers Cedex, France.
Alexander P A StegmannDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.
Erica H GerkesDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Marine TessarechDepartment of Biochemistry and Genetics, University Hospital, 49933 Angers Cedex 9, France; Equipe MitoLab, CNRS UMR 6015, Inserm U1083, Institut MitoVasc of Angers, CHU Bât IRIS/IBS, Rue des Capucins, 49933 Angers Cedex, France.
Dominique BonneauDepartment of Biochemistry and Genetics, University Hospital, 49933 Angers Cedex 9, France; Equipe MitoLab, CNRS UMR 6015, Inserm U1083, Institut MitoVasc of Angers, CHU Bât IRIS/IBS, Rue des Capucins, 49933 Angers Cedex, France.
Magalie BarthDepartment of Biochemistry and Genetics, University Hospital, 49933 Angers Cedex 9, France; Equipe MitoLab, CNRS UMR 6015, Inserm U1083, Institut MitoVasc of Angers, CHU Bât IRIS/IBS, Rue des Capucins, 49933 Angers Cedex, France.
Thomas BesnardCHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes Cedex, France.
Benjamin CognéCHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes Cedex, France.
Anya Revah-PolitiInstitute for Genomic Medicine, Columbia University, New York, NY 10032, USA.
Tim M StromInstitute of Human Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany; Institute of Human Genetics, Technical University of Munich, 81675 Munich, Germany.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Yaping YangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Jennifer E PoseyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
LaDonna ImmkenClinical Genetics, Specially for Children, Austin, TX 78723, USA.
Nelly OundjianValley Hospital, Ridgewood, NJ, USA.
Katherine L HelbigDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, California, USA.
Naomi MeeksDivision of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA; Clinical Genetics, Children's Hospital Colorado, Aurora, CO, USA.
Kelsey ZegarDivision of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA; Clinical Genetics, Children's Hospital Colorado, Aurora, CO, USA.
Jenny MortonWest Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's NHS Foundation Trust, B15 2TG Birmingham, UK.
DDD study
Jolanda H SchievingDepartment of Pediatric Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Ana ClaasenCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Matthew HuentelmanCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Vinodh NarayananCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Keri RamseyCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, Arizona, USA.
C4RCD Research Group
Han G BrunnerDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Orly ElpelegDepartment of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 9112001; Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 9112001.
Sandra MercierCHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes Cedex, France.
Stéphane BézieauCHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes Cedex, France.
Christian KubischInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Undiagnosed Disease Program at the University Medical Center Hamburg-Eppendorf (UDP-UKE), Martinistraße 52, 20246 Hamburg, Germany.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Stefan KindlerInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Texas Children's Hospital, Houston, TX 77030, USA; Baylor Genetics Laboratories, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Hans-Jürgen KreienkampInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Electronic address: kreienkamp@uke.de.
Baylor College of Medicine · USGénétique Médicale & Génomique Fonctionelle · FRRadboud University Nijmegen · NLTranslational Genomics Research Institute · USUniversität Hamburg · DEHadassah Medical Center · ILInserm · FRUniversity Medical Center Hamburg-Eppendorf · DEAmbry Genetics (United States) · USBirmingham Women’s and Children’s NHS Foundation Trust · GBCentre National de la Recherche Scientifique · FRChildren's Hospital Colorado · USColumbia University · USHelmholtz Zentrum München · DERadboud University Medical Center · NLUniversité d'Angers · FRUniversity of Colorado Denver · USUniversity of Groningen · NLValley Hospital · US

Funding

The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset diseaseK08HG008986 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI POSEY, JENNIFER ELLEN · 2017 to 2021
$831k
NHGRI NIH HHS K08 HG008986NHGRI NIH HHS U54 HG003273NHGRI NIH HHS UM1 HG006542
6 · The paper itself

Abstract

DHX30 is a member of the family of DExH-box helicases, which use ATP hydrolysis to unwind RNA secondary structures. Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities. While four mutations are recurrent, two are unique with one affecting the codon of one recurrent mutation. All amino acid changes are located within highly conserved helicase motifs and were found to either impair ATPase activity or RNA recognition in different in vitro assays. Moreover, protein variants exhibit an increased propensity to trigger stress granule (SG) formation resulting in global translation inhibition. Thus, our findings highlight the prominent role of translation control in development and function of the central nervous system and also provide molecular insight into how DHX30 dysfunction might cause a neurodevelopmental disorder.

Indexed as

Adenosine TriphosphatasesAdolescentAmino AcidsCell LineCell Line, TumorCentral Nervous SystemChildChild, PreschoolDevelopmental DisabilitiesFemaleHEK293 CellsHumansIntellectual DisabilityMaleMutation, MissenseRNAAdenosine TriphosphatasesAmino AcidsDHX30 protein, humanRNARNA Helicases

Identifiers

PMID29100085
PMCPMC5673606
OpenAlexW2766092441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.